AGM
WINT

Alpine Global Management’s Windtree Therapeutics Inc WINT Stock Holding History

Alpine Global Management’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,317
Closed -$21K – 591
2014
Q4 		$21K Buy
+1,317
New +$29K ﹤0.01% 578
2014
Q2 		– Sell
-794
Closed -$24K – 256
2014
Q1 		$24K Buy
+794
New +$26.7K 0.02% 151

Other funds holding WINT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Alpine Global Management's WINT Position: Q1 2015 in Review

Alpine Global Management sold out of Windtree Therapeutics Inc (WINT) in Q1 2015, closing a stake of 1,317 shares — an estimated $21K sold.

Alpine Global Management first reported a position in WINT in Q1 2014 and held it in 2 quarters. The position peaked at $24K in Q1 2014. 58 funds tracked by Wall St. Rank hold WINT as of Q1 2015.

  • Alpine Global Management reported no remaining Windtree Therapeutics Inc position as of Q1 2015 after selling out during the quarter.
  • Alpine Global Management sold 1,317 Windtree Therapeutics Inc shares in Q1 2015, an estimated $21K.
  • Alpine Global Management first reported a position in Windtree Therapeutics Inc in Q1 2014 and held it in 2 quarters.
  • Alpine Global Management's Windtree Therapeutics Inc position peaked at $24K in Q1 2014.
  • 58 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q1 2015.

Based on Alpine Global Management's 13F filing for Q1 2015, filed 5 May 2015.